share_log

Anika Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Trigran Investments, Inc.(Approximately 14.6%),Douglas Granat(Approximately 14.6%), etc.

阿尼卡疗法 | SC 13G/A:超过5%持股股东披露文件(修正)-Trigran Investments, Inc.(Approximately 14.6%),Douglas Granat(Approximately 14.6%)等

美股sec公告 ·  02/09 11:15
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息